Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC β-Nicotinamide mononucleotide, reduced form disodium | 108347-85-9 | 99.6% | 380.20 | C11H15N2Na2O8P | 10 MG
Supplier: Medchemexpress LLC HYW615108B10MG
β-Nicotinamide mononucleotide, reduced form disodium (NMNH) is the reduced form of β-nicotinamide mononucleotide and an orally active NAD+ precursor. It increases cellular NAD+ and NADH levels and is used in research to study metabolic pathways and cell growth. Supplied as a light yellow solid with high purity and recommended storage under inert atmosphere to preserve stability.
- Orally active NAD+ precursor that raises cellular NAD+/NADH levels.
- Reduced form of nicotinamide mononucleotide with distinct metabolic effects.
- Reported to inhibit glycolysis and affect the tricarboxylic acid cycle and cell growth.
- High purity suitable for research applications.
- Light yellow solid; store protected from light under nitrogen at -20°C.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?